Practical Management of Patients With Chronic Myeloid Leukemia Receiving Imatinib von DEININGER, Michael W. N, O'BRIEN, Stephen G, FORD, John M, DRUKER, Brian J

Volltext

Imatinib induces hematologic and cytogenetic responses in patients with chronic myelogenous leukemia in myeloid blast crisis: results of a phase II study von Sawyers, Charles L., Hochhaus, Andreas, Feldman, Eric, Goldman, John M., Miller, Carole B., Ottmann, Oliver G., Schiffer, Charles A., Talpaz, Moshe, Guilhot, Francois, Deininger, Michael W.N., Fischer, Thomas, O'Brien, Steve G., Stone, Richard M., Gambacorti-Passerini, Carlo B., Russell, Nigel H., Reiffers, Jose J., Shea, Thomas C., Chapuis, Bernard, Coutre, Steven, Tura, Sante, Morra, Enrica, Larson, Richard A., Saven, Alan, Peschel, Christian, Gratwohl, Alois, Mandelli, Franco, Ben-Am, Monique, Gathmann, Insa, Capdeville, Renaud, Paquette, Ronald L., Druker, Brian J.

Volltext

A phase 2 study of imatinib in patients with relapsed or refractory Philadelphia chromosome–positive acute lymphoid leukemias von Ottmann, Oliver G., Druker, Brian J., Sawyers, Charles L., Goldman, John M., Reiffers, Jose, Silver, Richard T., Tura, Sante, Fischer, Thomas, Deininger, Michael W., Schiffer, Charles A., Baccarani, Michele, Gratwohl, Alois, Hochhaus, Andreas, Hoelzer, Dieter, Fernandes-Reese, Sofia, Gathmann, Insa, Capdeville, Renaud, O'Brien, Stephen G.

Volltext

Effects of imatinib mesylate (STI571, Glivec) on the pharmacokinetics of simvastatin, a cytochrome P450 3A4 substrate, in patients with chronic myeloid leukaemia von O'Brien, S G, Meinhardt, P, Bond, E, Beck, J, Peng, B, Dutreix, C, Mehring, G, Milosavljev, S, Huber, C, Capdeville, R, Fischer, T

Volltext

Imatinib mesylate has limited activity against the central nervous system involvement of Philadelphia chromosome‐positive acute lymphoblastic leukaemia due to poor penetration into... von Takayama, Nobuyuki, Sato, Norihide, O'Brien, Stephen G., Ikeda, Yasuo, Okamoto, Shin‐ichiro

Volltext

Quality of Life in Patients With Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia on Imatinib Versus Interferon Alfa Plus Low-Dose Cytarabine: Results From the IRIS Study von HAHN, Elizabeth A, GLENDENNING, G. Alastair, CELLA, David, SORENSEN, Mark V, HUDGENS, Stacie A, DRUKER, Brian J, GUILHOT, Francois, LARSON, Richard A, O'BRIEN, Stephen G, DOBREZ, Deborah G, HENSLEY, Martee L

Volltext

De-escalation of tyrosine kinase inhibitor therapy before complete treatment discontinuation in patients with chronic myeloid leukaemia (DESTINY): a non-randomised, phase 2 trial von Clark, RE, Polydoros, F, Apperley, JF, Milojkovic, D, Rothwell, K, Pocock, C, Byrne, J, De Lavallade, H, Osborne, W, Robinson, L, O'Brien, SG, Read, L, Foroni, L, Copland, M

Volltext

De-escalation of tyrosine kinase inhibitor dose in patients with chronic myeloid leukaemia with stable major molecular response (DESTINY): an interim analysis of a non-randomised,... von Clark, RE, Polydoros, F, Apperley, JF, Milojkovic, D, Pocock, C, Smith, G, Byrne, JL, De lavallade, H, O'Brien, SG, Coffey, T, Foroni, L, Copland, M

Volltext

Prognostic factors for patients with chronic myeloid leukaemia in chronic phase treated with imatinib mesylate after failure of interferon alfa von Marin, D, Marktel, S, Bua, M, Szydlo, R M, Franceschino, A, Nathan, I, Foot, N, Crawley, C, Na Nakorn, T, Olavarria, E, Lennard, A, Neylon, A, O'Brien, S G, Goldman, J M, Apperley, J F

Volltext

Imatinib in patients with newly diagnosed chronic-phase chronic myeloid leukemia von O'Brien, Stephen G., Deininger, Michael W.N.

Volltext

Oligodeoxynucleotide-mediated inhibition of c-myb gene expression in autografted bone marrow: a pilot study von Luger, Selina M., O'Brien, Stephen G., Ratajczak, Janina, Ratajczak, Mariusz Z., Mick, Rosemarie, Stadtmauer, Edward A., Nowell, Peter C., Goldman, John M., Gewirtz, Alan M.

Volltext

Transient response to imatinib mesylate (STI571) in a patient with the ETV6-ABL t(9;12) translocation von O'Brien, Stephen G., Vieira, Sara A.D., Connors, Samantha, Bown, Nick, Chang, James, Capdeville, Renaud, Melo, Junia V.

Volltext

A single nucleotide polymorphism in the coding region of ABL and its effects on sensitivity to imatinib von Crossman, L C, O'Hare, T, Lange, T, Willis, S G, Stoffregen, E P, Corbin, A S, O'Brien, S G, Heinrich, M C, Druker, B J, Middleton, P G, Deininger, M W N

Volltext

Der9q deletions in CML: the next chapter in the story von O’Brien, Stephen G.

Volltext

Extramedullary blast crises in CML patients in complete hematological remission treated with imatinib mesylate von Simpson, E., O'Brien, S. G., Reilly, J. T.

Volltext

Managing cutaneous reactions to imatinib therapy von Rule, Simon A.J., O'Brien, Stephen G., Crossman, Lucy C.

Volltext

Position paper on imatinib mesylate in chronic myeloid leukaemia von O'Brien, Stephen G., Rule, Simon A. J.

Volltext

CD34+ cell selection in chronic phase chronic myeloid leukaemia : a comparison of laboratory grade columns von HAWKINS, T. E, MARLEY, S. B, O'BRIEN, S. G, GORDON, M. Y, GOLDMAN, J. M

Volltext

Imatinib for chronic myeloid leukaemia: a NICE mess von Rajaratnam, Giri, Edwards, John

Volltext

An update on chronic myeloid leukaemia von Stark, Gail, O’Brien, Stephen G

Volltext